WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of VIROPHARMA INC (VPHM)

Name VIROPHARMA INC
Year low 14.62
Year High 33.17
Symbol VPHM
Last trade 19.99
Percentage change 0.45
Volume 869,630
Media Volume (3m) 1,545,500
PE Ratio 12.88
EPS 1.545
Market Cap 1394
Media fatt 565
Trend fatt trend fatt graph for VIROPHARMA INC
Media net income 135
Trend net income trend net income for VIROPHARMA INC
P / E P / E graph for VIROPHARMA INC - 14 points 14
EPS EPS graph for VIROPHARMA INC - 14 points 14
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for VIROPHARMA INC - 4 points 4
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for VIROPHARMA INC - 2 points 2
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for VIROPHARMA INC - 0 points 0
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for VIROPHARMA INC - 12 points 12
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for VIROPHARMA INC - 5 points 5
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for VIROPHARMA INC - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for VIROPHARMA INC - 1 points 1
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for VIROPHARMA INC - 3 points 3
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for VIROPHARMA INC - 8 points 8
. . graph for VIROPHARMA INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for VIROPHARMA INC - 4 points 4
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for VIROPHARMA INC - 2 points 2
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for VIROPHARMA INC - 1 points 1
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for VIROPHARMA INC - 1 points 1
. . graph for VIROPHARMA INC - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for VIROPHARMA INC - 0 points 0
SINTESE 75

GRAPHS

max price logarithm graph for VIROPHARMA INC based on no conditions max volume linear graph for VIROPHARMA INC based on no conditions

News

ViroPharma To Participate In Two June Healthcare Investor Conferences (May 22 - reuters) Insider Buying Trends: Are These Cash-Rich Companies Ready For A Rally? (May 20 - reuters) Investor Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors with Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against ViroPharma Inc. (May 19 - reuters) Investing 101: Biotech Stocks With Insider Buying (May 19 - reuters) Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ViroPharma Incorporated (May 18 - reuters) Bacterial Resistance To Currently Marketed Drugs Is Creating A Window Of Opportunity For Biopharmaceutical Firms (May 17 - reuters) 3 Highly Shorted Biotech Stocks Being Bought Up By Insiders (May 08 - reuters) ViroPharma to Participate in Two May Healthcare Investor Conferences (May 02 - reuters) ViroPharma misses estimates, shares fall (May 01 - reuters) UPDATE 1-ViroPharma misses estimates, cuts revenue forecast (May 01 - reuters) ViroPharma misses estimates, cuts revenue forecast (May 01 - reuters) A Halo Comes Off (May 01 - reuters) Buyout Rumors Highlight Watson Pharmaceuticals (Apr 26 - reuters) ViroPharma To Release 2012 First Quarter Financial Results On May 1, 2012 (Apr 23 - reuters) Holzer Holzer & Fistel, LLC Announces Investigation into ViroPharma Incorporated (Apr 20 - reuters) Something to Watch at ViroPharma (Apr 19 - reuters) Critical Alerts for Qualcomm, Simon Property, Agnico Eagle Mines, Ivanhoe Mines, and ViroPharma Released by Seven Summits Research (Apr 17 - reuters) The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by ViroPharma Inc. (Apr 11 - reuters) ViroPharma And Generic Vancocin: A Contentious Issue (Apr 11 - reuters) Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ViroPharma, Inc. (Apr 11 - reuters) Prasco Expands Authorized Generic Product Line with Vancocin® HCl Capsules (Apr 11 - reuters) Investor Alert: Former Attorney General of Louisiana and Kahn Swick & Foti, LLC Investigate ViroPharma Inc., Following Disclosure of Federal Trade Commission Investigation (Apr 11 - reuters) Watson launches generic of ViroPharma's antibiotic (Apr 10 - reuters) UPDATE 1-Watson launches generic of ViroPharma's antibiotic (Apr 10 - reuters) ViroPharma Provides Update on Status of Citizen Petition Regarding Bioequivalence and Exclusivity for Vancocin® (vancomycin hydrochloride, USP) Capsules (Apr 10 - reuters) 3 Insider Stocks Picks Undervalued By EPS/Price Mismatches (Apr 04 - reuters) ViroPharma Launches Hereditary Angioedema Facebook App to Encourage Education and Diagnosis of Hereditary Angioedema Through Discussion of Family History (Mar 29 - reuters) Why ViroPharma May Be About to Take Off (Mar 23 - reuters) ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) (Mar 06 - reuters) ViroPharma Beats Up on Analysts Yet Again (Feb 29 - reuters) ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results (Feb 28 - reuters) Investors Brace for Volatile Durable Goods Orders (Feb 28 - reuters) These High-Flying Stocks Have Created New 52-Week Highs 3 Days In A Row (Feb 16 - reuters) Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism (Feb 16 - reuters) ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012 (Feb 15 - reuters) ViroPharma to Participate in Two Upcoming Healthcare Investor Conferences (Feb 14 - reuters) ViroPharma Provides Update on Industrial Scale Supplement for Cinryze® (C1 Esterase Inhibitor [Human]) (Feb 07 - reuters) 2 Biotech Stocks Leading This Rally (Feb 03 - reuters) Halozyme's New High (Feb 02 - reuters) Is ViroPharma's Growth for Real? (Jan 20 - reuters) Widespread Potential For Halozyme (Jan 17 - reuters) Biotechs: Has The Law Of Gravity Been Suspended? (Jan 13 - reuters) Health Canada Grants Priority Review Status For New Drug Submission (NDS) For Cinryze™ (C1 Inhibitor [human]) (Jan 13 - reuters) 8 Stocks Hitting New Highs Today (Jan 06 - reuters) ViroPharma Provides 2012 Outlook (Jan 06 - reuters) ViroPharma Announces Appointment of Julie H. McHugh to Board of Directors (Jan 04 - reuters) ViroPharma Is Poised For Gain (Jan 01 - reuters) Too Early for a New Biotech Orphan? (Dec 30 - reuters) ViroPharma buys right to acquire Meritage Pharma (Dec 23 - reuters) ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma (Dec 23 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY